ATE401912T1 - Methoden der zubereitung von immunglobulin und dessen verwendungen - Google Patents
Methoden der zubereitung von immunglobulin und dessen verwendungenInfo
- Publication number
- ATE401912T1 ATE401912T1 AT01971026T AT01971026T ATE401912T1 AT E401912 T1 ATE401912 T1 AT E401912T1 AT 01971026 T AT01971026 T AT 01971026T AT 01971026 T AT01971026 T AT 01971026T AT E401912 T1 ATE401912 T1 AT E401912T1
- Authority
- AT
- Austria
- Prior art keywords
- methods
- immunoglobulin
- preparation
- conditions
- provides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/660,862 US6962700B1 (en) | 2000-09-13 | 2000-09-13 | Method of manufacturing immune globulin |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE401912T1 true ATE401912T1 (de) | 2008-08-15 |
Family
ID=24651263
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01971026T ATE401912T1 (de) | 2000-09-13 | 2001-09-13 | Methoden der zubereitung von immunglobulin und dessen verwendungen |
Country Status (6)
Country | Link |
---|---|
US (2) | US6962700B1 (de) |
EP (1) | EP1320351B1 (de) |
AT (1) | ATE401912T1 (de) |
AU (1) | AU2001290962A1 (de) |
DE (1) | DE60134993D1 (de) |
WO (1) | WO2002022079A2 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2004087761A1 (ja) * | 2003-03-31 | 2006-07-27 | 麒麟麦酒株式会社 | ヒトモノクローナル抗体およびヒトポリクローナル抗体の精製 |
EP1799813B1 (de) * | 2004-10-13 | 2010-05-19 | Metabogal Ltd. | System und verfahren zur produktion von antikörpern in der pflanzenzellkultur |
TWI391399B (zh) * | 2005-05-25 | 2013-04-01 | Hoffmann La Roche | 測定溶離多肽之鹽濃度之方法 |
JP5064558B2 (ja) | 2007-06-01 | 2012-10-31 | エフ.ホフマン−ラ ロシュ アーゲー | 免疫グロブリン精製 |
US9107906B1 (en) | 2014-10-28 | 2015-08-18 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
US10232048B1 (en) | 2014-11-18 | 2019-03-19 | Divine Api-Logics, LLC | Apitherapy method and composition |
US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
US20220324961A1 (en) * | 2021-04-12 | 2022-10-13 | IgGenix, Inc. | Allergy therapy |
CN118660719A (zh) * | 2021-12-08 | 2024-09-17 | 艾吉尼克斯公司 | 用于过敏症疗法的组合 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4089944A (en) * | 1975-12-22 | 1978-05-16 | Baxter Travenol Laboratories, Inc. | Rapidly solubilized AHF composition and process for preparing same |
DE2837168A1 (de) | 1978-08-25 | 1980-03-06 | Blutspendedienst Dt Rote Kreuz | Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten immunglobulinloesung |
US4186192A (en) * | 1978-12-18 | 1980-01-29 | Cutter Laboratories, Inc. | Stabilized immune serum globulin |
JPS57206608A (en) | 1981-05-29 | 1982-12-18 | Mochida Pharmaceut Co Ltd | Production of gamma-globulin for intravenous injection |
US4639513A (en) | 1984-02-02 | 1987-01-27 | Cuno Inc. | Intravenously injectable immunoglobulin G (IGG) and method for producing same |
US4482483A (en) | 1983-04-06 | 1984-11-13 | Armour Pharmceutical Company | Composition of intravenous immune globulin |
US4719290A (en) | 1983-09-02 | 1988-01-12 | Armour Pharmaceutical Corporation | Composition of intravenous immune globulin |
US4597966A (en) * | 1985-01-09 | 1986-07-01 | Ortho Diagnostic Systems, Inc. | Histidine stabilized immunoglobulin and method of preparation |
JPS61286754A (ja) | 1985-06-12 | 1986-12-17 | Shionogi & Co Ltd | モノクロ−ナル抗ヒトIgG↓4抗体およびその製造法 |
US5346687A (en) * | 1989-08-09 | 1994-09-13 | Rhomed Incorporated | Direct radiolabeling of antibody against stage specific embryonic antigen for diagnostic imaging |
US5177194A (en) | 1990-02-01 | 1993-01-05 | Baxter International, Inc. | Process for purifying immune serum globulins |
CA2078805C (en) | 1992-09-22 | 1997-02-25 | Intelcor Biotech Enterprises Inc. | Cytokine preparation |
US5489519A (en) * | 1992-10-27 | 1996-02-06 | Queen's University At Kingston | Multidrug resistance protein |
IT1257184B (it) * | 1992-12-22 | 1996-01-10 | Applied Research Systems | Preparato ad attivita' antinfiammatoria, anticoagulante e antitumorale |
FR2706466B1 (fr) | 1993-06-14 | 1995-08-25 | Aetsrn | Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré. |
US6165981A (en) * | 1995-03-07 | 2000-12-26 | Dade Behring Inc. | Stabilizing solutions for proteins and peptides |
DK2270044T3 (en) * | 1998-06-09 | 2015-01-26 | Csl Behring Ag | Liquid immunoglobulin G (IgG) product |
-
2000
- 2000-09-13 US US09/660,862 patent/US6962700B1/en not_active Expired - Fee Related
-
2001
- 2001-09-13 US US09/952,778 patent/US7276236B2/en not_active Expired - Fee Related
- 2001-09-13 AT AT01971026T patent/ATE401912T1/de not_active IP Right Cessation
- 2001-09-13 EP EP01971026A patent/EP1320351B1/de not_active Expired - Lifetime
- 2001-09-13 AU AU2001290962A patent/AU2001290962A1/en not_active Abandoned
- 2001-09-13 DE DE60134993T patent/DE60134993D1/de not_active Expired - Fee Related
- 2001-09-13 WO PCT/US2001/028830 patent/WO2002022079A2/en active Search and Examination
Also Published As
Publication number | Publication date |
---|---|
AU2001290962A1 (en) | 2002-03-26 |
US6962700B1 (en) | 2005-11-08 |
US20020064526A1 (en) | 2002-05-30 |
EP1320351A4 (de) | 2004-07-28 |
WO2002022079A2 (en) | 2002-03-21 |
EP1320351B1 (de) | 2008-07-23 |
EP1320351A2 (de) | 2003-06-25 |
DE60134993D1 (de) | 2008-09-04 |
US7276236B2 (en) | 2007-10-02 |
WO2002022079A3 (en) | 2002-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE419009T1 (de) | Methoden und zusammensetzungen bestehend aus glykoprotein-glykoformen | |
DK0703922T3 (da) | Fremgangsmåde til fremstilling af immunoglobulin G koncentrat | |
BR9502707A (pt) | Composto composição farmacêutica e método para o tratamento de uma afecção | |
CY1107628T1 (el) | Ανθρωπινα ctla-4 αντισωματα και χρησεις αυτων | |
IL178474A0 (en) | Monoclonal antibodies to hepatocyte growth factor and pharmaceutical compositions containing the same | |
GEP20227392B (en) | Humanized antibody for treating or preventing cognitive disorders, process for producing the same, and agent for treating or preventing cognitive disorders using the same | |
ATE401912T1 (de) | Methoden der zubereitung von immunglobulin und dessen verwendungen | |
ATE439381T1 (de) | Reinigung von polyreaktiven autoantikörpern und deren verwendungen | |
ATE151078T1 (de) | Verfahren und zwischenprodukte synthetischer antikörperderivate | |
CR20220421A (es) | Anticuerpos anti-cd19 humano | |
DE60215649D1 (de) | Zusammensetzungen und verfahren zur behandlung von hyperimmunreaktionen im auge | |
DE60035693D1 (de) | Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten | |
ATE425187T1 (de) | Materialien und methoden zur behandlung von hepatitis c | |
DE69029858D1 (de) | Behandlung von einer autoimmun-krankheit | |
ATE540694T1 (de) | Verfahren zur behandlung der thrombozytopenie mit monoklonalem ivig | |
MX2022012404A (es) | Composiciones que comprenden 15-hepe para tratar o prevenir trastornos hematológicos y/o enfermedades relacionadas. | |
EA202191220A1 (ru) | НОВЫЕ МОЧЕВИНО-6,7-ДИГИДРО-4H-ПИРАЗОЛО[4,3-с]ПИРИДИНЫ, АКТИВНЫЕ ПРОТИВ ВИРУСА ГЕПАТИТА В (HBV) | |
MX2023009447A (es) | Anticuerpos que se unen a metapneumovirus, proteínas antigénicas de metapneumovirus, y usos de los mismos. | |
ATE304372T1 (de) | Immunmodulatorisch wirksame zusammensetzungen, verfahren zu ihrer herstellung und ihre verwendung | |
MXPA03010829A (es) | Uso de inmunoglobulinas policlonales. | |
ATE412423T1 (de) | Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion | |
DK0470989T3 (da) | Anvendelse af monoklonale anti-beta2 mikroglobulin antistoffer | |
DE60041266D1 (de) | Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten | |
EA202190875A1 (ru) | ЛЕЧЕНИЕ КОМПОЗИЦИЯМИ ВЫСОКОСИАЛИЛИРОВАННОГО IgG | |
MX2022002447A (es) | Composiciones y métodos para el tratamiento de la infección por influenza a. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |